HIV Prevention Decision Tool for Young Adults
Part of Infections clinical trials.
This study tests a simple online tool to help young people decide whether PrEP (a daily pill that prevents HIV) might be right for them. The tool uses information from an at-home HIV test and is designed to make PrEP information easier to understand.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 39 years old
- Be comfortable reading and speaking English
- Have internet access to use the online tool
- Be HIV negative (based on your self-report or test result)
- Have never taken PrEP before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program called PrEP Choice to help young people learn about and start PrEP, a daily pill that prevents HIV. It aims to see if offering choices in PrEP care makes it easier to use.
This trial tests a digital toolkit to help women start taking PrEP, a medication that prevents HIV. It looks at whether the toolkit makes it easier for women to take PrEP consistently.
This study is creating a decision-making tool to help transgender women choose the right PrEP (HIV prevention pill) for them. It is looking for transgender women in Denver who are HIV-negative and interested in learning more about PrEP, as well as healthcare providers who help transgender women decide about PrEP.
This study helps young adults who have had contact with the criminal legal system access HIV prevention services and support for substance use. Researchers will connect you with health resources and track whether an app-based service helps you stay healthy and engaged with care.
This study asks people who may use PrEP—an HIV prevention medicine—about their decision to start, not start, or stop PrEP. It aims to understand needs and barriers so PrEP can work better for cisgender women and transgender people who are considering it.
This trial tests a decision support tool that helps emergency department patients learn about PrEP (a daily pill that prevents HIV). It is for people who are HIV negative and not already taking HIV prevention medicine.
Hear when a new Pre-Exposure Prophylaxis (PrEP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.